Eli Lilly and Company has announced a definitive agreement to acquire clinical-stage biopharmaceutical firm AtaiBeckley in a transaction valued at up to $3.8 billion. The acquisition aims to significa...

The U.S. Food and Drug Administration has granted approval to Otsuka Pharmaceutical for SIMTRIYO (centanafadine), marking the first regulatory clearance for a norepinephrine, dopamine, serotonin reupt...

Key Regulatory ProposalsSanofi has officially terminated its clinical development program for amlitelimab, an OX40-ligand targeting monoclonal antibody previously intended for the treatment of moderat...

On July 16, 2026, the Centers for Medicare & Medicaid Services (CMS) issued a new draft guidance that fills in critical operational details for the Inflation Reduction Act’s drug price negotiation pro...

The Centers for Medicare & Medicaid Services (CMS) has unveiled a comprehensive, three-pillar strategy aimed at fundamentally restructuring Original Medicare (OM) by transitioning away from traditiona...

The European Commission has issued marketing authorization for once-daily oral semaglutide 25 mg tablets, marketed under the Wegovy brand, for the management of obesity and weight-associated comorbidi...

The U.S. Food and Drug Administration (FDA) has approved Celcuity’s REVTORPYK (gedatolisib) for the treatment of HR+/HER2- metastatic breast cancer patients who do not possess a PIK3CA mutation. As th...

The Centers for Medicare & Medicaid Services (CMS) has introduced a broad regulatory proposal aimed at restructuring Medicare physician payments and accelerating the transition toward value-based care...